X

Trial Profile

A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Investigate the Efficacy and Tolerability of Topiramate in Prolonged Migraine Prevention

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 14 Jan 2020

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Topiramate (Primary)
Indications Migraine
Focus Therapeutic Use
Acronyms PROMPT
Sponsors Janssen

Most Recent Events

04 Apr 2012 Additional trial locations added as reported by ClinicalTrials.gov.
23 Jun 2009 Actual patients number changed from 818 to 834 as reported by ClinicalTrials.gov.
23 Jun 2009 Actual end date (Aug 2006) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com